Brewin Dolphin LTD Ligand Pharmaceuticals Inc Transaction History

Brewin Dolphin LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Nov 14, 2022	SELL	$94.99 - $151.56 $6,649 - $10,609	-70 Closed	0 $0
Q4 2021 Nov 14, 2022	BUY	$127.69 - $165.85 $8,938 - $11,609	70 New	70 $11,000
Q1 2021 Nov 09, 2023	SELL	$99.52 - $215.83 $11,245 - $24,388	-113 Reduced 61.75%	70 $10.7 Million
Q2 2020 Nov 09, 2023	SELL	$68.28 - $123.65 $11,949 - $21,638	-175 Reduced 48.88%	183 $20.5 Million
Q3 2019 Nov 09, 2023	BUY	$86.25 - $120.16 $15,093 - $21,028	175 Added 95.63%	358 $35.6 Million
Q2 2018 Nov 09, 2023	SELL	$150.77 - $207.98 $150 - $207	-1 Reduced 0.54%	183 $37.9 Million
Q3 2017 Nov 09, 2023	BUY	$120.91 - $137.94 $22,247 - $25,380	184	184 $25.1 Million

277

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.83B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin LTD with notifications on news.